Oruka Therapeutics GAAP EPS of -$0.55 misses by $0.01 (NASDAQ:ORKA)
Oruka Therapeutics press release (ORKA): Q2 GAAP EPS of -$0.55 misses by $0.01. As of June 30, 2026, Oruka had cash, cash equivalents and marketable securities
YayaNews contributes financial news and market context through the YayaNews editorial workflow.
Oruka Therapeutics press release (ORKA): Q2 GAAP EPS of -$0.55 misses by $0.01. As of June 30, 2026, Oruka had cash, cash equivalents and marketable securities
Oruka Therapeutics GAAP EPS of -$0.55 misses by $0.01 (NASDAQ:ORKA) | Seeking Alpha
Oruka Therapeutics
press release
(
ORKA
): Q2 GAAP EPS of -$0.55
misses by $0.01
.
As of June 30, 2026, Oruka had cash, cash equivalents, and marketable securities of $1.1 billion. The company expects these funds to be sufficient to fund operations through an anticipated BLA filing for ORKA-001 and continued development of ORKA-002.
More on Oruka Therapeutics
Oruka Therapeutics Is Priced For Perfection - It's Time To Cash Out
Oruka Therapeutics - Intriguing Long Acting Psoriasis Programs May Need Further Derisking
Seeking Alphaâs Quant Rating on Oruka Therapeutics
Historical earnings data for Oruka Therapeutics
Financial information for Oruka Therapeutics
To ensure this doesnât happen in the future, please enable Javascript and cookies in your browser.
Is this happening to you frequently? Please
report it on our feedback forum.
If you have an ad-blocker enabled you may be blocked from proceeding. Please disable your ad-blocker and refresh.
Search field
Entering text into the input field will update the search result below
Recommended For You
More
Trending News
See More
»
Original YayaNews editorial coverage, published for informational purposes.
This article is sourced from Seeking Alpha. It is for informational purposes only and does not constitute investment advice.
Topics & Symbols
Continue Reading
Related Reading
Bowman Consulting Non-GAAP EPS of $0.62 beats by $0.16, revenue of $146.12M beats by $0.32M (NASDAQ:BWMN)
Bowman Consulting press release (BWMN): Q2 Non-GAAP EPS of $0.62 beats by $0.16. Revenue of $146.12M (+19.7% Y/Y) beats by $0.32M. Full Year 2026 Guidance Bowma
Powerfleet Raises FY2027 Guidance: South Africa Contract Drives Annualized Revenue to $495M with 27% EBITDA Margin
Powerfleet projects FY2027 Q4 annualized revenue of $495 million and adjusted EBITDA margin of 27%, driven by a major South Africa contract. The guidance upgrade signals strong growth and market confidence.
Berkshire Earnings Beat, GameStop Adjusts Financing; Midday Market Roundup
Berkshire Hathaway's quarterly operating profit beat expectations and cash reserves hit a record high, while GameStop modified its convertible notes terms. Tech stocks were mixed and energy strengthened, with markets eyeing inflation data and Fed speeches.
Imperial Brands prepares for a round of job cuts in Europe and the U.S. (IMBBY:OTCMKTS)
Imperial Brands (IMMBY) plans major U.S./Europe job cuts to lower costs amid falling cigarette demand.
